[go: up one dir, main page]

WO2009054483A1 - Drug containing salusin-β - Google Patents

Drug containing salusin-β Download PDF

Info

Publication number
WO2009054483A1
WO2009054483A1 PCT/JP2008/069307 JP2008069307W WO2009054483A1 WO 2009054483 A1 WO2009054483 A1 WO 2009054483A1 JP 2008069307 W JP2008069307 W JP 2008069307W WO 2009054483 A1 WO2009054483 A1 WO 2009054483A1
Authority
WO
WIPO (PCT)
Prior art keywords
salusin
drug containing
drug
intended
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/069307
Other languages
French (fr)
Japanese (ja)
Inventor
Masayoshi Shichiri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProteinExpress Co Ltd
Tokyo Medical and Dental University NUC
Original Assignee
ProteinExpress Co Ltd
Tokyo Medical and Dental University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProteinExpress Co Ltd, Tokyo Medical and Dental University NUC filed Critical ProteinExpress Co Ltd
Publication of WO2009054483A1 publication Critical patent/WO2009054483A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

It is intended to provide a novel drug. Thus, a drug containing salusin-β as the active ingredient is provided.
PCT/JP2008/069307 2007-10-26 2008-10-24 Drug containing salusin-β Ceased WO2009054483A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007279006 2007-10-26
JP2007-279006 2007-10-26

Publications (1)

Publication Number Publication Date
WO2009054483A1 true WO2009054483A1 (en) 2009-04-30

Family

ID=40579585

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/069307 Ceased WO2009054483A1 (en) 2007-10-26 2008-10-24 Drug containing salusin-β

Country Status (1)

Country Link
WO (1) WO2009054483A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016222630A (en) * 2015-06-03 2016-12-28 学校法人北里研究所 Treatment or prevention agent for angiogenesis-related diseases, screening method and kit
JP2019076117A (en) * 2019-02-18 2019-05-23 学校法人北里研究所 Screening methods for therapeutic or prophylactic agent for angiogenesis related diseases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095609A1 (en) * 2004-04-02 2005-10-13 Japan Science And Technology Agency Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005095609A1 (en) * 2004-04-02 2005-10-13 Japan Science And Technology Agency Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SHICHIRI M., ENDOCRINOLOGY & DIABETOLOGY, vol. 22, no. 4, 2006, pages 459 - 463 *
ZHIWEI WANG, EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 539, 2006, pages 145 - 150 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016222630A (en) * 2015-06-03 2016-12-28 学校法人北里研究所 Treatment or prevention agent for angiogenesis-related diseases, screening method and kit
JP2019076117A (en) * 2019-02-18 2019-05-23 学校法人北里研究所 Screening methods for therapeutic or prophylactic agent for angiogenesis related diseases

Similar Documents

Publication Publication Date Title
USD688128S1 (en) Bottle cap
USD582633S1 (en) Pocket
USD591029S1 (en) Pocket
WO2010030598A3 (en) Pharmaceutical formulations comprising pemetrexed
MX2010005889A (en) Novel thiophene derivatives.
WO2009039951A3 (en) Active ingredient combinations having insecticidal and acaricidal properties
WO2008131114A3 (en) Pharmaceutical formulations containing lipoic acid derivatives
WO2009057079A3 (en) Novel pyrimidine derivatives
EP1888728A4 (en) Fatty acid analogues, i.e. dha derivatives for uses as a medicament
EP2172238A4 (en) Drug solution injector
WO2009030469A8 (en) Fungicidal 2-alkylthio-2-quinolinyloxy-acetamide deritvatives
WO2011120904A3 (en) A fast dissolving pharmaceutical composition
EP2058024A4 (en) Medicine sprayer
TW200942524A (en) Novel aminomethyl benzene derivatives
WO2011009938A3 (en) Stambomycin and derivatives, their production and their use as drugs
WO2008116147A3 (en) Structured compositions comprising a clay
WO2011120903A3 (en) A fast dissolving pharmaceutical composition
WO2009055289A3 (en) Therapeutic substituted lactams
EA200900958A1 (en) DRUG NEVIRAPIN PREPARATION
WO2007138562A3 (en) Concentrated perfume compositions
WO2009103813A3 (en) Fungicidal compositions comprising 3'-bromine-2,3,4,6'-tetramethoxy-2'-6-dimethylbenzophenone
WO2009156724A3 (en) Pyrido-indole-carboxylic acid compounds
WO2008146883A1 (en) Sleep-improving agent
WO2009075250A1 (en) Plant disease control agent
UA96476C2 (en) Pharmaceutical composition comprising irbesartan

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08841805

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08841805

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP